Forskningsoutput per år
Forskningsoutput per år
- 9 resultat
Sökresultat
-
2024
The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden – data from the Swedish Macula Register
Wickman, I., Lövestam-Adrian, M., Granstam, E., Kjellström, U. & Schroeder, M., 2024 dec., I: BMC Ophthalmology. 24, 1, 49.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång -
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice
Guymer, R., Bailey, C., Chaikitmongkol, V., Chakravarthy, U., Chaudhary, V., Finger, R. P., Gallego-Pinazo, R., Chuan, A. K. H., Ishida, S., Lövestam-Adrian, M., Parravano, M., Luna Pinto, J. D., Schmitz-Valckenberg, S., Sheth, V., Souied, E. H., Chi, G. C., Gilberg, F., Glittenberg, C., Scheidl, S. & Bengus, M., 2024 maj 1, I: Ophthalmology Science. 4, 3, 100442.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång -
2022
A novel phenotype associated with the R162W variant in the KCNJ13 gene
Schroeder, M., Peter, V. G., Gränse, L., Andréasson, S., Rivolta, C. & Kjellström, U., 2022, I: Ophthalmic Genetics. 43, 4, s. 500-507 8 s.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång -
Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration
Schroeder, M., Kjellström, U. & Lövestam-Adrian, M., 2022, I: Documenta Ophthalmologica. 144, 2, s. 99-115Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång -
Exploration of real-world outcomes and treatment patterns in patients treated with anti-vascular endothelial growth factors for neovascular age-related macular degeneration in Sweden
Schroeder, M., Westborg, I., Fluur, C., Olsen, R. & Lövestam-Adrian, M., 2022, I: Acta Ophthalmologica. 100, 4Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång -
What about the fellow eye in treatment of neovascular age-related macular degeneration? Analysis of data from the Swedish macula register
Lövestam Adrian, M., Schroeder, M. & Westborg, I., 2022, I: Acta Ophthalmologica. 100, 7 , s. 769-774Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång -
2020
Evaluation of different macular degenerations. Function, morphology and clinical outcomes.
Schroeder, M. S., 2020, Lund: Lund University, Faculty of Medicine. 65 s.Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)
Öppen tillgångFil340 Nedladdningar (Pure) -
2019
Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration: data from the INSIGHT study using the Swedish Macula Register
Lövestam Adrian, M., Vassilev, Z. P. & Westborg, I., 2019, I: Acta Ophthalmologica. 97, 1, s. 91-98Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
-
2017
No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same swedish county treated for wet age-related macular degeneration
Schroeder, M., Rung, L. & Lövestam-Adrian, M., 2017 juni 9, I: Clinical Ophthalmology. 11, s. 1105-1111 7 s.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång